Belite Bio – Phase 2/3 Trial for Adolescents with Stargardt disease
The latest research news piece from Retina UK.
Search results
The latest research news piece from Retina UK.
Join Colin and Linda McArthur for their annual Isle of Wight walk, in aid of Retina UK's 50th anniversary.
Opus Genetics has launched an early-stage clinical trial of OPGx-MERTK, an investigational gene therapy for MERTK-related Retinitis Pigmentosa (RP), a condition that causes progressive vision loss due to photoreceptor degeneration.
The cover of this edition celebrates the success of our amazing London Marathon team. Together they have raised more than £43,000.
Making yourself aware of the what you are entitled to, and understanding the diagnosis pathway for inherited sight loss, will put you in a stronger position to seek better support.
Your doctor or genetic counsellor will spend some time asking about other people in your family to try to work out the way in which your particular faulty gene has been passed down through the generations – this is referred to as the inheritance pattern.
Since the publication of this newsletter our founder and honorary president Lynda Cantor MBE has passed away. We are all deeply saddened by this news.
Inside this edition, register now for our AI webinar on 7 December with Dr Nikolas Pontikos.